Contact Us

19000 33rd Ave W.
Suite 130
Lynnwood, WA 98036-4753
United States
PR Contact
Chris Joseph
(510) 435-4031
chris.joseph@volparaheal...

More »

Volpara provides an advanced AI software platform that works with a healthcare provider’s expertise to enable a high-quality, optimized, and personalized cancer screening experience. From the time a patient enters a clinic to the moment they obtain key results, the Volpara Breast Health Platform collects and analyzes information to better understand a patient’s breast cancer risk, while also objectively evaluating image quality and workflow-improvement opportunities. These capabilities are being extended to lung cancer screening. The Volpara Breast Health Platform is supported by numerous patents, trademarks, and regulatory registrations including FDA clearance and CE marking, and is validated by a volume of peer-reviewed publications unrivaled in the breast screening industry. 

 

News Releases
Nov 29, 2021

CHICAGO, November 29, 2021 – Volpara Health, (ASX: VHT) showcases its integrated platform for the delivery of personalized breast care, at the 107th Annual Radiological Society of North America...

Nov 22, 2021

SEATTLE, NOVEMBER 4, 2021 -- Volpara Health, (ASX: VHT) and leading mammography education provider, Mammography Educators, LLC, have expanded their collaboration...

Oct 11, 2021

LYNNWOOD, WASHINGTON, OCTOBER 11, 2021 -- Volpara Health is proud to have reached their 200th peer-reviewed paper milestone, making the Volpara AI breast health platform the most independently validated of its kind...

Sep 23, 2021

SEATTLE, SEPTEMBER 23, 2021 -- Volpara Health, (ASX: VHT), a global health technology software leader providing an integrated platform for the delivery of personalized breast and lung care, further expanded its footprint in the US lung screening market...

Jul 29, 2021

SEATTLE, JULY 29, 2021 -- Volpara Health, a global health technology software leader providing an integrated breast care platform for the delivery of personalized breast care, has received FDA clearance for...

More »